Ningbo Menovo Pharmaceutical News

Menovar: Announcement of Ningbo Menohua Pharmaceutical Co., Ltd. on changing the sponsor representative for continuous supervision

Jan 9 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on changing the sponsor representative for continuous supervision

Jan 9 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the 2025 Interest Payment of “Minuo Bonds”

Jan 8 00:00

Ningbo Menova Pharmaceutical Co., Ltd. Convertible debt-to-share conversion results and share change announcement

Jan 3 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on not revising the “Mino Bonds” conversion price downward

Dec 14, 2024 00:00

An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the “Mino Bonds Transfer” expected to meet the conditions for the downward revision of the share conversion price

Dec 7, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate for metformin vigliptin tablets (II)

Dec 5, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on participating in the 4th to 5th batch of centralized procurement of nationally organized drugs selected by the Jiangsu Alliance in successive procurement

Nov 27, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on repurchase and cancellation of some restricted shares and notification of reduction of registered capital to creditors

Nov 22, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on not revising the “Mino Bonds” conversion price downward

Nov 2, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate for ambromoterol oral solution

Oct 31, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate for agliptin benzoate tablets

Oct 31, 2024 00:00

An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the “Mino Bonds Transfer” expected to meet the conditions for the downward revision of the share conversion price

Oct 26, 2024 00:00

Menovar: Announcement of Ningbo Menohua Pharmaceutical Co., Ltd. on signing a strategic cooperation agreement with Nanjing Warwick Pharmaceutical Technology Group Co., Ltd.

Oct 9, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on signing a strategic cooperation agreement with Nanjing Warwick Pharmaceutical Technology Group Co., Ltd.

Oct 9, 2024 00:00

Ningbo Menova Pharmaceutical Co., Ltd. Convertible debt-to-share conversion results and share change announcement

Oct 9, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on not revising the “Mino Bonds” conversion price downward

Sep 14, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on increasing capital to its wholly-owned subsidiary Ningbo Menohua Tiankang Pharmaceutical Co., Ltd.

Aug 31, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a duloxetine hydrochloride enteric capsule drug registration certificate

Aug 29, 2024 00:00

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the holding subsidiary arginine perindopril API passing the CDE technical review

Aug 28, 2024 00:00